HER2-targeted oncolytic HSV therapy (Universita di Bologna)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHER2-targeted oncolytic HSV therapy (Universita di Bologna)
Drug Alias Nameengineered R-LM11 HSVengineered R-LM113 HSVengineered R-LM11L HSVengineered R-LM249 HSV
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Bologna
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Bologna
Active IndicationsN/A
Inactive IndicationsNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A